Aims of the Committee

To increase the role of the IAC as a facilitator of research in the field of clinical cytology and stimulate the publications of guidelines, classifications, and nomenclature.

Specific Topics

  • To implement the decisions of the strategy meeting namely reinforce and continue the collaboration with WHO-IARC-IAC for publications, explore the educational online possibilities with Karger, review the contract with Karger for the possibility of an online only option for Acta for some IAC members, revise the newsletter model and reinforce the social media tools
  • To establish training platforms of IAC to be used for the teaching of juniors to fill the gaps in the basic issues in research such as statistical analysis

Chair: Lukas Bubendorf, MIAC
Members: Andrew Field, Martha Pitman, Kari Syränen
Members ex-officio: Massimo Bongiovanni and Fernando Schmitt



Professor Bubendorf is head of the Cytopathology Division at the Institute for Pathology of the University Hospital Basel, Basel, Switzerland.
His major interests and diagnostic expertise lie within lung pathology and uropathology, and in the general field of cytopathology. His research group currently investigates the role of genomic evolution and heterogeneity in solid tumors, including lung and prostate cancer. In cytology, he aims at translating molecular techniques and assays to clinical routine application


Andrew Field, MB BS (Hons), FRCPA, FIAC

Dr. Field is head of the Department of Anatomical Pathology at St Vincent’s Hospital, Sydney, and Associate Professor at the University of New South Wales and Notre Dame University Medical Schools. He is currently the President of the International Academy of Cytology and a foundation member of African Strategies for Advancing Pathology, an organization that aims to advocate for and coordinate improvements in pathology services throughout Africa.

Dr. Martha Pitman, MIAC

Dr. Pitman is an internationally recognized expert in the field of cytopathology and fine needle aspiration cytopathology in general, and pancreaticobiliary cytopathology in particular. She is a Professor of Pathology at Harvard Medical School and practicing pathologist in cytopathology and gastrointestinal surgical pathology at Massachusetts General Hospital.
She has been Associate Editor of Cancer Cytopathology and The Journal of the American Society of Cytopathology and is currently active on the editorial boards of several journals. She is the lead author of the PSC Pancreaticobiliary Terminology System for reporting pancreaticobiliary cytology as well as the new WHO Reporting System for Pancreaticobiliary Cytology. She is also on the Standing Committee (one of 5 series editors) for all WHO Reporting Systems. Her clinical research is devoted to the investigation of the early detection of pancreatic cancer, especially in association with mucinous pancreatic cysts.

Dr. Kari Syränen, FIAC

Dr. Syrjänen was Professor and Chairman, Department of Pathology, University of Kuopio & Head of the Department of Clinical Pathology, Kuopio University Hospital in 1989-1999, and Director of Cytopathology Laboratory, Finnish Cancer Society (Kuopio) for 16 years (1981-1996). As well as Editor in Chief of Acta Cytologica, he is an Editorial Board member in 17 other journals and Associate Editor-in-Chief (CME Journal of Gynecologic Oncology). Dr. Syrjänen has authored/edited 9 international books, written over 50 book chapters